Senior or Staff Scientist, Perturb-seq – Foster City, CA (San Francisco Bay Area)
Illumina
Summary
Illumina is seeking a highly motivated and talented experimental and computational scientist to lead high-throughput genome-wide perturb-seq experiments to discover new biological pathways and validate targets identified from human genetics.
Job description
Roles and Responsibilities
- Build the team and laboratory infrastructure for running high-throughput sequencing experiments for target identification and validation.
- Design, develop and validate quantitative cellular assays to credential novel targets.
- Work closely with academic and clinical collaborators to integrate innovative biology with data from large-scale human genetics and high throughput sequencing assays to develop new target hypotheses.
- Present results at scientific meetings and publish in peer-reviewed scientific journals.
- Provide direct technical mentorship and mentorship for lab-based staff.
Requirements
- Ph.D in cell biology, molecular biology, bioengineering, or similar degree
- At least 4+ years of experience
- Extensive expertise with experimental and computational biology techniques
- Development and analysis of high-throughput sequencing assays
- Single cell sequencing
- CRISPR
- Cell culture and IPSC models
- Target identification and target validation
- Strong record of technical proficiency, innovation, and scientific rigor as demonstrated by publication in high-quality scientific journals
Benefits
- Health insurance
- Dental insurance
- Vision insurance
- Retirement benefits
- Paid time off
- Genomics sequencing access
- Family planning
- Bonus program
- Equity
Company overview
Illumina is a global leader in genomics technology, founded in 1998 and headquartered in San Diego, California. As a pioneering biotechnology company, Illumina specializes in developing, manufacturing, and marketing integrated systems for genetic analysis, with a primary focus on DNA sequencing and array-based technologies. The company's mission is to improve human health by unlocking the power of the genome, serving customers across research, clinical, and applied markets worldwide. Illumina's innovative platforms, including the NovaSeq, HiSeq, MiSeq, and NextSeq series, have revolutionized genomic research and clinical applications, enabling breakthroughs in personalized medicine, disease research, and drug development. With over 9,000 employees across 27 countries, Illumina has established itself as the dominant force in next-generation sequencing, processing more than 90% of all DNA sequencing data globally. The company's technologies support diverse applications from cancer research and rare disease diagnosis to agricultural genomics and infectious disease surveillance, making genomic insights accessible to researchers and clinicians worldwide.